Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
I am both a long-term multiple myeloma survivor and MM cancer coach. I have supplemented with curcumin since 2006. I live an evidence-based, non-toxic, anti-MM lifestyle through nutrition, supplementation (curcumin, others), bone health, detox, mind-body and more.
This link is to the Google search page for “curcumin in myeloma.” Whether it is an article authored by Pat Killingsworth or Margaret from Margaret’s Corner, curcumin is documented to be both cytotoxic to myeloma in addition to being “integrative” or enhancing the action of Velcade, Revlimid, and Thalidomide.
The study linked below as an ideal example of integrative cancer therapy. That is to say, combining both conventional myeloma therapies (thalidomide/ bortezomib/Velcade with non-conventional therapy such as curcumin.)
If you would like to learn more about other evidence-based, integrative therapies that integrate with and/or fight multiple myeloma, click the button below to sign up for a FREE webinar by clicking the blue button below:
Have you been diagnosed with multiple myeloma? What stage? Have you begun therapy? Scroll down the page, post a question or comment and will reply to you ASAP.
Background: Curcumin, the active component of the Curcuma longa plant, has been shown to potentiate the effect of the immunomodulatory drugs (IMiDs) thalidomide and Bortezomib against human myeloma cell lines and a nude mice model…
Conclusion: Curcumin exerts a cytotoxic effect additive to that of lenalidomide on H929 myeloma cells, and it also enhances the chemo-sensitizing effects of this agent.